Benzinga | Jul 14, 2021 07:10AM EDT

European OK's Use Of Saliva Samples With Hologic's Aptima COVID-19 Test

* Hologic Inc (NASDAQ:HOLX) has obtained a CE Mark to use saliva samples with its Aptima SARS-CoV-2 assay in Europe.

* The Aptima SARS-CoV-2 test is a molecular diagnostic assay that detects the pathogen's genetic material causing COVID-19.

* The test runs on the fully automated Panther system.

* Hologic has expanded its manufacturing capability to produce Aptima tests in large quantities and has shipped more than 100 million Aptima COVID-19 tests globally since the spring of 2020.

* Approximately 2,600 Panther systems have been installed in clinical diagnostic laboratories around the world.

* Price Action: HOLX shares closed at $68.65 on Tuesday.